Ascentage Pharma raises $126m in 1st biotech IPO of 2025
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.
Private credit lenders are flocking to finance large, fast-growing technology companies gearing up to go public, taking ...
Private equity-backed Northpointe Bancshares filed for an initial public offering in the United States on Thursday, setting ...
The company's public listing is set to attract attention as it aims to raise Rs 600 crore with shares priced between Rs ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback